SMG5

gene
On this page

Also known as KIAA1089LPTS-RP1LPTSRP1RP11-54H19.7SMG-5EST1B

Summary

SMG5 (SMG5 nonsense mediated mRNA decay factor, HGNC:24644) is a protein-coding gene on chromosome 1q22, encoding Nonsense-mediated mRNA decay factor SMG5 (Q9UPR3). Plays a role in nonsense-mediated mRNA decay. It is a common-essential gene (DepMap: required in 98.4% of cancer cell lines).

SMG5 is involved in nonsense-mediated mRNA decay (Ohnishi et al., 2003 [PubMed 14636577]).

Source: NCBI Gene 23381 — RefSeq curated summary.

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 237 total
  • Cancer dependency (DepMap): dependent in 98.4% of screened cell lines (common-essential)
  • MANE Select transcript: NM_015327

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24644
Approved symbolSMG5
NameSMG5 nonsense mediated mRNA decay factor
Location1q22
Locus typegene with protein product
StatusApproved
AliasesKIAA1089, LPTS-RP1, LPTSRP1, RP11-54H19.7, SMG-5, EST1B
Ensembl geneENSG00000198952
Ensembl biotypeprotein_coding
OMIM610962
Entrez23381

Gene structure

Transcript identifiers

Ensembl transcripts: 26 — 22 protein_coding, 3 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000361813, ENST00000468993, ENST00000473643, ENST00000476954, ENST00000489907, ENST00000858600, ENST00000858601, ENST00000858602, ENST00000858603, ENST00000858604, ENST00000858605, ENST00000858606, ENST00000858607, ENST00000858608, ENST00000858609, ENST00000858610, ENST00000925518, ENST00000925519, ENST00000925520, ENST00000925521, ENST00000956492, ENST00000956493, ENST00000956494, ENST00000956495, ENST00000956496, ENST00000956497

RefSeq mRNA: 5 — MANE Select: NM_015327 NM_001323614, NM_001323615, NM_001323616, NM_001323617, NM_015327

CCDS: CCDS1137

Canonical transcript exons

ENST00000361813 — 22 exons

ExonStartEnd
ENSE00001054400156261333156261408
ENSE00001054402156267470156267678
ENSE00001054403156251403156251477
ENSE00001054404156252414156252504
ENSE00001054405156268290156268415
ENSE00001054406156263395156263570
ENSE00001054407156273361156273450
ENSE00001054409156268115156268183
ENSE00001054410156272320156272398
ENSE00001054413156266541156266678
ENSE00001054415156252919156253078
ENSE00001054416156260451156260626
ENSE00001054417156265781156266380
ENSE00001054418156250858156250996
ENSE00001075011156277925156278048
ENSE00001075015156277085156277241
ENSE00001075017156274597156274686
ENSE00001196892156278936156279034
ENSE00001446733156249224156250670
ENSE00001446734156282607156282825
ENSE00003436026156259005156259163
ENSE00003442982156253449156253508

Expression profiles

Bgee: expression breadth ubiquitous, 286 present calls, max score 96.19.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 54.5890 / max 347.1460, expressed in 1825 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
1509754.21281825
150993.50021173
150980.2801137
150960.096028

Top tissues by expression

294 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
apex of heartUBERON:000209896.19gold quality
lower esophagus mucosaUBERON:003583496.11gold quality
metanephros cortexUBERON:001053395.25gold quality
gastrocnemiusUBERON:000138895.20gold quality
adenohypophysisUBERON:000219694.92gold quality
right adrenal glandUBERON:000123394.91gold quality
granulocyteCL:000009494.90gold quality
right hemisphere of cerebellumUBERON:001489094.89gold quality
C1 segment of cervical spinal cordUBERON:000646994.82gold quality
right adrenal gland cortexUBERON:003582794.77gold quality
left adrenal gland cortexUBERON:003582594.69gold quality
left adrenal glandUBERON:000123494.68gold quality
skin of legUBERON:000151194.62gold quality
muscle of legUBERON:000138394.50gold quality
cerebellar hemisphereUBERON:000224594.48gold quality
mucosa of transverse colonUBERON:000499194.45gold quality
right frontal lobeUBERON:000281094.44gold quality
skin of abdomenUBERON:000141694.42gold quality
heart left ventricleUBERON:000208494.40gold quality
cerebellar cortexUBERON:000212994.35gold quality
pituitary glandUBERON:000000794.26gold quality
right atrium auricular regionUBERON:000663194.20gold quality
adrenal cortexUBERON:000123594.14gold quality
cardiac ventricleUBERON:000208294.14gold quality
right lobe of liverUBERON:000111494.08gold quality
hindlimb stylopod muscleUBERON:000425294.05gold quality
ventricular zoneUBERON:000305393.98gold quality
lower esophagusUBERON:001347393.96gold quality
lower esophagus muscularis layerUBERON:003583393.95gold quality
upper lobe of left lungUBERON:000895293.92gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.88

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

80 targeting SMG5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-12118100.0065.881270
HSA-MIR-118499.9968.191458
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-433-3P99.9869.371203
HSA-MIR-185-3P99.9567.011743
HSA-MIR-1236-3P99.9468.041695
HSA-MIR-6845-3P99.9466.881439
HSA-MIR-3151-5P99.8663.831069
HSA-MIR-477999.8666.501583
HSA-MIR-807399.8665.211118
HSA-MIR-221-5P99.8665.451052
HSA-MIR-431999.7669.832586
HSA-MIR-92A-2-5P99.7567.012164
HSA-MIR-430699.7270.503630
HSA-MIR-64699.6867.841645
HSA-MIR-320299.6667.702737
HSA-MIR-182799.6368.573265
HSA-MIR-613299.6065.831554
HSA-MIR-6836-5P99.6065.621538
HSA-MIR-671-5P99.5267.111277
HSA-MIR-6722-3P99.4567.621919
HSA-MIR-125A-5P99.3670.591640
HSA-MIR-125B-5P99.3670.361662
HSA-MIR-196A-3P99.1967.341204
HSA-MIR-7109-5P99.1866.131057
HSA-MIR-478499.1567.411733
HSA-MIR-312599.1468.492269
HSA-MIR-4758-3P99.1263.96869
HSA-MIR-328-5P99.0864.651000

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 98.4% of screened cell lines, common-essential.

Literature-anchored findings (GeneRIF, showing 9)

  • Data show that phosphorylated hUPF1, the human ortholog of UPF1/SMG-2, forms a complex with human orthologs of the Caenorhabditis elegans proteins SMG-5 and SMG-7. (PMID:14636577)
  • HDAC8 regulation of hEST1B protein stability modulates total telomerase enzymatic activity (PMID:16809764)
  • The study demonstrates that SMG5-SMG7 and SMG6 exhibit different and non-overlapping modes of UPF1 recognition, thus pointing at distinguished roles in integrating the complex nonsense-mediated mRNA decay interaction network. (PMID:25013172)
  • Depletion of nonsense-mediated mRNA decay pathway components Upf1, Smg5, and Smg7 led to increased levels of viral proteins and and virus release. (PMID:25211080)
  • This study highlights that miR-433 represses nonsense mediated mRNA decay. The miR-433 targets 3’-UTR of SMG5 and represses the expression of SMG5, whereas nonsense-mediated mRNA decay activity is decreased when SMG5 is decreased. (PMID:27473591)
  • The authors found no evidence for the existence of a physical or functional interaction between SMG5 and PNRC2. (PMID:29348139)
  • SMG5-SMG7 authorize nonsense-mediated mRNA decay by enabling SMG6 endonucleolytic activity. (PMID:34172724)
  • Pan-Cancer Analysis of the Prognostic and Immunological Role of SMG5: A Biomarker for Cancers. (PMID:37699361)
  • Overexpression of TMEM79 combined with SMG5 is related to prognosis, tumor immune infiltration and drug sensitivity in hepatocellular carcinoma. (PMID:37936239)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriosmg5ENSDARG00000041481
mus_musculusSmg5ENSMUSG00000001415
rattus_norvegicusSmg5ENSRNOG00000019590
drosophila_melanogasterSmg5FBGN0019890

Paralogs (1): SMG7 (ENSG00000116698)

Protein

Protein identifiers

Nonsense-mediated mRNA decay factor SMG5Q9UPR3 (reviewed: Q9UPR3)

Alternative names: EST1-like protein B, LPTS-RP1, LPTS-interacting protein, SMG-5 homolog

All UniProt accessions (1): Q9UPR3

UniProt curated annotations — full annotation on UniProt →

Function. Plays a role in nonsense-mediated mRNA decay. Does not have RNase activity by itself. Promotes dephosphorylation of UPF1. Together with SMG7 is thought to provide a link to the mRNA degradation machinery involving exonucleolytic pathways, and to serve as an adapter for UPF1 to protein phosphatase 2A (PP2A), thereby triggering UPF1 dephosphorylation. Necessary for TERT activity.

Subunit / interactions. Interacts with TERT, PPP2CA and SMG1. Part of a complex that contains SMG1, SMG5, SMG7, PPP2CA, a short isoform of UPF3A (isoform UPF3AS, but not isoform UPF3AL) and phosphorylated UPF1. Not detected in complexes that contain unphosphorylated UPF1.

Subcellular location. Cytoplasm. Nucleus.

Tissue specificity. Ubiquitous.

RefSeq proteins (5): NP_001310543, NP_001310544, NP_001310545, NP_001310546, NP_056142* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002716PIN_domDomain
IPR011990TPR-like_helical_dom_sfHomologous_superfamily
IPR018834DNA/RNA-bd_Est1-typeDomain
IPR019458Est1-like_NDomain
IPR045153Est1/Ebs1-likeFamily

Pfam: PF10373, PF10374, PF13638

UniProt features (30 total): helix 7, strand 5, sequence conflict 4, modified residue 3, compositionally biased region 3, region of interest 2, initiator methionine 1, chain 1, sequence variant 1, mutagenesis site 1, domain 1, coiled-coil region 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
2HWYX-RAY DIFFRACTION2.75

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9UPR3-F173.720.45

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (3): 2, 423, 2

Mutagenesis-validated functional residues (1):

PositionPhenotype
860abolishes stimulation of rent1 dephosphorylation.

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-975957Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
R-HSA-8953854Metabolism of RNA
R-HSA-927802Nonsense-Mediated Decay (NMD)

MSigDB gene sets: 199 (showing top): GOBP_RNA_TEMPLATED_DNA_BIOSYNTHETIC_PROCESS, PID_HDAC_CLASSI_PATHWAY, RNGTGGGC_UNKNOWN, GOBP_CHROMOSOME_ORGANIZATION, PID_TELOMERASE_PATHWAY, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN, GOBP_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING, GOBP_TELOMERE_ORGANIZATION, CAGCTG_AP4_Q5, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, PATIL_LIVER_CANCER, GOBP_NUCLEAR_TRANSPORT, GOBP_REGULATION_OF_TELOMERE_MAINTENANCE, GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT

GO Biological Process (5): nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184), mRNA export from nucleus (GO:0006406), regulation of telomere maintenance (GO:0032204), regulation of telomere maintenance via telomerase (GO:0032210), regulation of dephosphorylation (GO:0035303)

GO Molecular Function (6): ubiquitin protein ligase binding (GO:0031625), telomeric repeat DNA binding (GO:0042162), histone deacetylase binding (GO:0042826), protein phosphatase 2A binding (GO:0051721), telomerase RNA binding (GO:0070034), protein binding (GO:0005515)

GO Cellular Component (5): nucleus (GO:0005634), telomerase holoenzyme complex (GO:0005697), cytoplasm (GO:0005737), cytosol (GO:0005829), cytoplasmic ribonucleoprotein granule (GO:0036464)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Nonsense-Mediated Decay (NMD)1
Metabolism of RNA1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
cytoplasm2
nuclear-transcribed mRNA catabolic process1
RNA export from nucleus1
gene expression1
mRNA transport1
telomere maintenance1
regulation of chromosome organization1
regulation of DNA metabolic process1
telomere maintenance via telomerase1
regulation of telomere maintenance via telomere lengthening1
regulation of DNA biosynthetic process1
dephosphorylation1
regulation of metabolic process1
ubiquitin-like protein ligase binding1
sequence-specific DNA binding1
enzyme binding1
protein phosphatase binding1
RNA binding1
binding1
intracellular membrane-bounded organelle1
nuclear protein-containing complex1
catalytic complex1
ribonucleoprotein complex1
intracellular anatomical structure1
ribonucleoprotein granule1

Protein interactions and networks

STRING

1814 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SMG5UPF1Q92900999
SMG5SMG7Q92540991
SMG5UPF2Q9HAU5978
SMG5SMG6Q86US8970
SMG5SMG1Q96Q15962
SMG5UPF3AQ9H1J1960
SMG5PNRC2Q9NPJ4951
SMG5UPF3BQ9BZI7934
SMG5SMG8Q8ND04903
SMG5SMG9Q9H0W8847
SMG5SULT1E1P49888832
SMG5HDAC8Q9BY41819
SMG5STAU1O95793789
SMG5XRN1Q8IZH2775
SMG5DCP1AQ9NPI6744

IntAct

35 interactions, top by confidence:

ABTypeScore
TP53CSNK2A2psi-mi:“MI:0914”(association)0.730
UPF3BRNPS1psi-mi:“MI:0914”(association)0.640
SMG7UPF1psi-mi:“MI:0914”(association)0.620
UPF1SMG7psi-mi:“MI:0914”(association)0.620
MRPS18CMRPS14psi-mi:“MI:0914”(association)0.530
SMG5SMG7psi-mi:“MI:0914”(association)0.500
UPF1SMG5psi-mi:“MI:0915”(physical association)0.500
SMG5SMG7psi-mi:“MI:0915”(physical association)0.500
DDX21MED19psi-mi:“MI:2364”(proximity)0.480
SMG5H2BC13psi-mi:“MI:0915”(physical association)0.400
SMG5H2BC21psi-mi:“MI:0915”(physical association)0.400
SMG5H2BC5psi-mi:“MI:0915”(physical association)0.400
SMG5TERTpsi-mi:“MI:0915”(physical association)0.400
TP53MDM2psi-mi:“MI:0914”(association)0.350
C6orf141KRBA1psi-mi:“MI:0914”(association)0.350
UPF1PABPC1psi-mi:“MI:0914”(association)0.350
UPF3ARNPS1psi-mi:“MI:0914”(association)0.350
SYT2ARHGAP10psi-mi:“MI:0914”(association)0.350
CFAP184TARS3psi-mi:“MI:0914”(association)0.350
DUSP16MEIOCpsi-mi:“MI:0914”(association)0.350
TP53PPM1Gpsi-mi:“MI:0914”(association)0.350
CEP152CNOT1psi-mi:“MI:2364”(proximity)0.270
PCM1CCDC66psi-mi:“MI:2364”(proximity)0.270
CPEB1CNOT1psi-mi:“MI:2364”(proximity)0.270
RB1CC1TRAPPC13psi-mi:“MI:2364”(proximity)0.270

BioGRID (92): SMG5 (Affinity Capture-RNA), SMG5 (Affinity Capture-RNA), SMG5 (Affinity Capture-Western), SMG5 (Proximity Label-MS), SMG5 (Proximity Label-MS), SMG5 (Proximity Label-MS), SMG5 (Affinity Capture-MS), SMG5 (Affinity Capture-MS), SMG5 (Affinity Capture-MS), SMG5 (Affinity Capture-MS), SMG5 (Reconstituted Complex), SMG5 (Affinity Capture-MS), SMG5 (Proximity Label-MS), SMG5 (Proximity Label-MS), SMG5 (Proximity Label-MS)

ESM2 similar proteins: A2A690, A2AWP8, A2RRU4, F1LQY6, F1LTE0, F1LXF1, O88842, O94827, O95267, P11274, P49797, Q0P5I0, Q14161, Q14CM0, Q29RM4, Q3B7L5, Q3UHE1, Q5JSP0, Q5R5M3, Q5R5T1, Q5T6S3, Q5XIS9, Q66H91, Q66T02, Q68FF6, Q6PAJ1, Q6RFZ7, Q6ZN54, Q6ZPY2, Q6ZR37, Q76JQ2, Q7Z6G3, Q80YA9, Q8BZ03, Q8R1S4, Q8TBP0, Q8TCU6, Q8WXI2, Q91ZP9, Q96JH8

Diamond homologs: A9QM73, F1R7R1, Q6ZPY2, Q9UPR3

SIGNOR signaling

2 interactions.

AEffectBMechanism
STUB1“down-regulates quantity by destabilization”SMG5polyubiquitination
HDAC8“up-regulates quantity by stabilization”SMG5binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 39 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)622.5×5e-05
Oxidative Stress Induced Senescence517.4×1e-03
Ub-specific processing proteases510.2×3e-03

GO biological processes:

GO termPartnersFoldFDR
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay566.9×4e-06

Disease & clinical

Clinical variants and AI predictions

ClinVar

237 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance183
Likely benign10
Benign6

Top pathogenic / likely-pathogenic (0)

SpliceAI

3227 predictions. Top by Δscore:

VariantEffectΔscore
1:156250853:CCCA:Cdonor_loss1.0000
1:156250854:CCAC:Cdonor_loss1.0000
1:156250855:CA:Cdonor_loss1.0000
1:156250856:A:AGdonor_loss1.0000
1:156250857:C:Adonor_loss1.0000
1:156252409:CTCA:Cdonor_loss1.0000
1:156252412:A:ACdonor_gain1.0000
1:156252412:A:Cdonor_loss1.0000
1:156252413:C:CAdonor_loss1.0000
1:156252413:C:CCdonor_gain1.0000
1:156252500:GATCA:Gacceptor_gain1.0000
1:156252501:ATCA:Aacceptor_gain1.0000
1:156252502:TCA:Tacceptor_gain1.0000
1:156252503:CA:Cacceptor_gain1.0000
1:156252503:CAC:Cacceptor_gain1.0000
1:156252505:C:CCacceptor_gain1.0000
1:156252508:G:GCacceptor_gain1.0000
1:156252513:C:CTacceptor_gain1.0000
1:156252514:A:Tacceptor_gain1.0000
1:156252517:G:Cacceptor_gain1.0000
1:156252517:G:GCacceptor_gain1.0000
1:156252913:ACTT:Adonor_gain1.0000
1:156252914:CTTA:Cdonor_loss1.0000
1:156252915:TTA:Tdonor_loss1.0000
1:156252915:TTAC:Tdonor_gain1.0000
1:156252916:TACC:Tdonor_gain1.0000
1:156252917:ACCT:Adonor_gain1.0000
1:156252918:C:CAdonor_loss1.0000
1:156252918:CCTGT:Cdonor_gain1.0000
1:156253444:CCTA:Cdonor_loss1.0000

AlphaMissense

6651 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:156252441:A:GL909P1.000
1:156252479:C:AK896N1.000
1:156252479:C:GK896N1.000
1:156252492:A:GL892P1.000
1:156253008:A:TV858D1.000
1:156253011:A:GL857P1.000
1:156253015:A:CY856D1.000
1:156253062:A:GL840P1.000
1:156253062:A:TL840Q1.000
1:156253077:A:GL835P1.000
1:156253453:A:GL833P1.000
1:156253453:A:TL833H1.000
1:156253459:A:GL831P1.000
1:156253465:G:TA829D1.000
1:156253467:C:AM828I1.000
1:156253467:C:GM828I1.000
1:156253467:C:TM828I1.000
1:156253468:A:GM828T1.000
1:156253476:C:AM825I1.000
1:156253476:C:GM825I1.000
1:156253476:C:TM825I1.000
1:156253477:A:GM825T1.000
1:156253480:A:GL824P1.000
1:156268394:A:CF245L1.000
1:156268394:A:TF245L1.000
1:156268396:A:GF245L1.000
1:156272377:C:TG219D1.000
1:156272378:C:GG219R1.000
1:156273447:C:GR183P1.000
1:156274602:T:AD180V1.000

dbSNP variants (sampled 300 via entrez): RS1000026223 (1:156261113 C>T), RS1000164096 (1:156255040 G>A), RS1000195361 (1:156254219 C>G,T), RS1000242419 (1:156291240 A>G), RS1000247671 (1:156254486 C>A,G,T), RS1000274171 (1:156261267 G>A,C,T), RS1000394508 (1:156267170 T>C), RS1000528571 (1:156285065 G>C), RS1000549210 (1:156278538 T>A), RS1000665367 (1:156291779 C>T), RS1000718076 (1:156271614 C>A,T), RS1000919072 (1:156271366 T>C), RS1001065838 (1:156271390 A>G), RS1001137568 (1:156253306 G>A,C), RS1001150904 (1:156259501 C>T)

Disease associations

OMIM: gene MIM:610962 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

4 associations (top):

StudyTraitp-value
GCST000582_7Mean corpuscular hemoglobin concentration3.000000e-09
GCST005145_1Glycated hemoglobin levels3.000000e-08
GCST005992_1Mean corpuscular hemoglobin concentration1.000000e-16
GCST006001_7Hemoglobin A1c levels1.000000e-18

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0004509hemoglobin measurement
EFO:0004528mean corpuscular hemoglobin concentration
EFO:0004541HbA1c measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

29 total (human), top 29 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects expression, increases abundance, decreases methylation, increases expression, affects cotreatment3
sodium arseniteincreases abundance, increases expression2
aristolochic acid Iincreases expression1
FR900359affects phosphorylation1
bisphenol Faffects cotreatment, increases expression1
ginger extractaffects cotreatment, affects expression, increases abundance1
dicrotophosincreases expression1
triphenyl phosphateaffects expression1
trichostatin Aaffects expression1
ICG 001increases expression1
abrineincreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acidincreases expression1
Sunitinibdecreases expression1
Leflunomidedecreases expression1
Arsenicincreases abundance, increases expression1
Atrazinedecreases expression1
Dexamethasoneaffects cotreatment, increases expression1
Indomethacinaffects cotreatment, increases expression1
Oils, Volatileincreases abundance, affects cotreatment, affects expression1
Seleniumaffects cotreatment, decreases expression, increases expression1
Smokedecreases expression1
Thiramincreases expression1
Valproic Acidincreases methylation1
Vitamin Eaffects cotreatment, decreases expression, increases expression1
1-Methyl-3-isobutylxanthineincreases expression, affects cotreatment1
Cyclosporineincreases expression1
Aflatoxin B1increases methylation1
Cadmium Chlorideincreases expression1
Copper Sulfatedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.